Wuhan General Group (China), Inc. (OTCPK:WUHN) signed a non-binding Letter of Intent to acquire MJ MedTech Inc. on October 4, 2018. The transaction would include all assets, including production/manufacturing, distribution, licenses, formulations and IP. The transaction is subject to the negotiation and execution of a definitive agreement and certain other customary conditions including the receipt of all necessary regulatory approvals. The transaction is expected to close in the fourth quarter of 2018. As of November 19, 2018, the deal is expected to close on December 15, 2018.